BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
54.89
-0.31 (-0.56%)
At close: Oct 8, 2026, 4:00 PM EDT
54.89
0.00 (0.00%)
After-hours: Oct 8, 2026, 4:00 PM EDT
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of $10.62 billion as of October 8, 2026. It is the 2,057th most valuable company in the world and the 731st biggest in the United States. Its market cap has increased by 1.13% in one year.
Market Cap
10.62B
Enterprise Value
13.95B
1-Year Change
1.13%
Global Rank
Country Rank
#731 United States
Category
ChartMarket Cap Chart
Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $10.62B, an increase of 2,295.66%. That is a compound annual growth rate of 12.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 10.62B | -6.96% |
| Dec 31, 2025 | 11.42B | -8.86% |
| Dec 31, 2024 | 12.53B | -31.03% |
| Dec 29, 2023 | 18.16B | -5.57% |
| Dec 30, 2022 | 19.23B | 18.58% |
| Dec 31, 2021 | 16.22B | 1.90% |
| Dec 31, 2020 | 15.92B | 4.81% |
| Dec 31, 2019 | 15.19B | 0.17% |
| Dec 31, 2018 | 15.16B | -3.18% |
| Dec 29, 2017 | 15.66B | 9.92% |
| Dec 30, 2016 | 14.25B | -15.66% |
| Dec 31, 2015 | 16.89B | 26.72% |
| Dec 31, 2014 | 13.33B | 33.25% |
| Dec 31, 2013 | 10.00B | 64.58% |
| Dec 31, 2012 | 6.08B | 54.81% |
| Dec 30, 2011 | 3.93B | 42.26% |
| Dec 31, 2010 | 2.76B | 45.68% |
| Dec 31, 2009 | 1.89B | 6.63% |
| Dec 31, 2008 | 1.78B | -48.15% |
| Dec 31, 2007 | 3.43B | 128.90% |
| Dec 29, 2006 | 1.50B | 87.98% |
| Dec 30, 2005 | 796.50M | 93.28% |
| Dec 31, 2004 | 412.10M | -16.92% |
| Dec 31, 2003 | 496.00M | 31.08% |
| Dec 31, 2002 | 378.40M | -36.33% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 12.93B |
| Halozyme Therapeutics | 12.57B |
| Bio-Techne | 11.37B |
| Madrigal Pharmaceuticals | 11.27B |
| ImmunityBio | 10.33B |
| Vaxcyte | 9.96B |
| Twist Bioscience | 9.76B |
| Krystal Biotech | 9.61B |